Michael Adduct of Sulfonamide Chalcone Targets Folate Metabolism in Brugia Malayi Parasite

Author:

Bhoj Priyanka S.1ORCID,Bahekar Sandeep P.2,Chowdhary Shambhavi1,Togre Namdev S.1ORCID,Amdare Nitin P.1ORCID,Jena Lingaraj1,Goswami Kalyan1,Chandak Hemant2ORCID

Affiliation:

1. Department of Biochemistry, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha 411002, India

2. Department of Chemistry, G. S. Science, Arts and Commerce College, Sant Gadge Baba Amravati University, Khamgaon 444303, India

Abstract

A series of Michael adducts of malononitrile and sulfonamide chalcones were synthesized, characterized, and evaluated for their antifilarial activity. Out of 14 compounds, N-(4-(4,4-dicyano-3-p-tolylbutanoyl)phenyl)benzenesulfonamide showed favorable drug-likeness properties with marked antifilarial effects at micro-molar dosages. Apoptosis in Brugia malayi microfilariae was confirmed by EB/AO staining, MTT assay, and cytoplasmic cytochrome c ELISA. Since chalcone and folate synthesis pathways share the same substrate, we hypothesize a structural analogy-based inhibition of folate metabolism by this compound. Molecular docking against a pre-validated BmDHFR protein showed more favorable thermodynamic parameters than a positive control, epicatechin-3-gallate. The compound significantly suppressed the DHFR activity in a parasite extract in vitro. Our hypothesis is also supported by a significant reversal of DHFR inhibition by folate addition, which indicated a plausible mechanism of competitive inhibition. These results demonstrate that targeting filarial folate metabolism through DHFR with consequent apoptosis induction might be rewarding for therapeutic intervention. This study reveals a novel rationale of the structural analogy-based competitive inhibition of DHFR by Michael adducts of sulfonamide chalcones.

Funder

Department of Biotechnology

Department of Science and Technology

UGC New Delhi, India

Publisher

MDPI AG

Subject

General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)

Reference26 articles.

1. World Health Organization (WHO) (2022, December 01). Lymphatic Filariasis. Available online: https://www.who.int/health-topics/lymphatic-filariasis#tab=tab_1.

2. Mass Drug Administration Programme against Lymphatic Filariasis-an Evaluation of Coverage and Compliance in a Northern Karnataka District, India;Kulkarni;Clin. Epidemiol. Glob. Health,2020

3. Progress in the Elimination of Lymphatic Filariasis in the Western Pacific Region: Successes and Challenges;Yajima;Int. Health,2020

4. Tripathi, B., Roy, N., and Dhingra, N. (2022). Introduction of Triple-Drug Therapy for Accelerating Lymphatic Filariasis Elimination in India: Lessons Learned. Am. J. Trop. Med. Hyg., 29–38.

5. Behm, C.A., Bendig, M.M., McCarter, J.P., and Sluder, A.E. (2022, December 01). WHO/TDR Scientific Working Group on “RNA Interference as a Means of Identifying Drug Targets for Filariasis Report. Available online: https://www.semanticscholar.org/paper/For-the-Web-Only-Who%2Ftdr-Scientific-Working-Group-a-Behm-Bendig/e3cd5111be68b7591b9e12a21d75405aa68cccd3.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3